1 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics of 221 cases treated in 27 Rosai Hospitals Second Report Stage Ⅳ Stage Ⅰ 7.3 Stage Ⅱ 35.8 Best supportive therapy 33.2 Surgery 25.0 Stage Ⅲ Chemotherapy 41.8 Clinical Research Center for Asbestos-Related Diseases Japan Labour Health and Welfare Organization Ikuji Usami, MD Vice Director General, Asahi Rosai Hospital
2 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Objective Asbestos-related diseases have become a pressing social issue in Japan. In June 2005, a high incidence of was reported among residents in the vicinity of the old Kubota Kanzaki Plant and compensation was paid to those affected. The Rosai Hospital group, a part of the Japan Labour Health and Welfare Organization, rapidly surveyed cases at Rosai Hospitals nationwide in May 2006, and published an interim report* called the Survey of lung cancer and malignant cases associated with asbestos exposure. The report closely investigated the relationship between the clinical characteristics of and occupational asbestos exposure. In this report, we further investigated the clinical characteristics of an additional 221 cases of in Japan. *References 1) Kishimoto T., Kimura K., Usami I., et al., Interim report of Survey of lung cancer and malignant cases associated with asbestos exposure, Japan Labour Health and Welfare Organization, May ) Kishimoto T., Kimura K., Usami I., et al., Interim report of Survey of lung cancer and malignant cases associated with asbestos exposure, Occupational Health Journal 29: 7-22, ) Booklet edited by Japan Labour Health and Welfare Organization, Clinical characteristics of in Japan: Summary of 132 patients treated at Rosai Hospital Group, Japan Labour Health and Welfare Organization Methods In this report, there were 221 cases clinically or pathologically diagnosed as from January 2000 to January 2008 at 27 Rosai Hospitals.
3 Survey of Mesothelioma Associated with Asbestos Exposure in Japan Characteristics of cases Results Primary site Characteristics of cases by primary site Pleura Peritoneum Pericardium Tunica vaginalis Number of cases Age: Mean SD Sex: Male Female Includes two cases of unknown origin Primary site and Sex Tunica vaginalis 0.9 Pericardium 1.8 Unknown0.9 Peritoneum 13.1 Female 16.3 Pleura 83.3 Male 83.7 Primary site Sex The mean age was 66.1 years old. From the total of 221 cases, 83.3% were diagnosed with pleural and 83.7% of the total cases were male. Clinical characteristics of 221 cases treated in 27 Rosai Hospitals
4 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Motivation for diagnoses Subjective symptoms Region Motivation for diagnoses Pleura Peritoneum Pericardium Tunica vaginalis Subjective symptom Regular health check-up During treatment for other diseases, etc Subjective symptoms based on primary site Pleural 135 Peritoneal 26 Chest/Back pain 55 Abdominal distension 18 Dyspnea 53 Abdominal pain 5 Cough 24 Others 6 Fever 12 Others 9 Patients exhibited multiple symptoms. Many cases were identified based on the presence of subjective symptoms. Methodological procedures for diagnosis Chest/back pain and dyspnea were noted frequently in cases of pleural, and abdominal distension was frequently noted in peritoneal. Diagnostic procedures for Pleural Peritoneal Pericardial Mesothelioma of the tunica vaginalis Number of cases Histological diagnosis: Thoracotomy/laparotomy VATS/Laparoscopy Thoracoscopy under local anesthesia Needle biopsy Cope needle biopsy Autopsy Number of histologically diagnosed cases Number of histologically non-diagnosable cases Cytology Unknown From 219 cases, % were diagnosed histologically.
5 Survey of Mesothelioma Associated with Asbestos Exposure in Japan Hyaluronic acid concentration in pleural or peritoneal effusion Hyaluronic acid concentration in pleural or peritoneal effusion ng/ml Pleural Peritoneal Number of cases Mean 197,116 2,184,074 SD 315,085 4,805,492 Maximum 1,870,000 13,000,000 Minimum >100,000 cases Hyaluronic acid concentration was determined in 94 cases (51.1%) from 184 pleural cases. Histological type of Number of cases Number of examined cases out of total number of patients above Histological type of Pleural Peritoneal 29 Epitheloid type Sarcomatoid type Biphasic type Unclassified Pericardium, Tunica vaginalis, and unclassifiable cases were included. Biphasic type 14.5 Sarcomatoid type 25.1 Unclassified 6.3 Epitheloid type 54.1 From 207 cases, 112 (54.1%) were epitheloid type, 52 (25.1%) were sarcomatoid type, 30 (14.5%) were biphasic type, and 13 (6.3%) were unclassified. Clinical characteristics of 221 cases treated in 27 Rosai Hospitals
6 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Staging of pleural (IMIG classification) Staging of pleural Stage Number of cases 40 Treatment: Surgery 18 Chemotherapy 3 Ⅰ Stage Ⅱ Stage Ⅲ Stage Ⅳ Best supportive therapy 15 Unknown Five cases were excluded where the stage was unknown. 29.6% were diagnosed at an early stage (Stage I or II). Better efforts to establish early detection are important. Treatment of Treatment of Number of cases Surgery Chemotherapy Best supportive therapy Pleural Peritoneal One case each of pericardial and of of the tunica vaginalis were surgically resected. Surgical resection was performed in 25.0% of pleural cases and 6.9% of peritoneal cases. Best supportive therapy 33.2 Pleural Surgery 6.9 Best supportive therapy 24.1 Surgery 25.0 Chemotherapy 41.8 Chemotherapy 69.0 Peritoneal
7 Survey of Mesothelioma Associated with Asbestos Exposure in Japan Survival time Survival rate (%) Survivability of patients with Survival time (days) The median survival time was 300 days when including all types of. Survivability of patients with by primary site Survival rate (%) Peritoneal Pleural Survival time (days) The median survival time was 299 days for cases of pleural, and 170 days for cases of peritoneal. Clinical characteristics of 221 cases treated in 27 Rosai Hospitals
8 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survivability of patients with by stage Survival rate (%) Survival time (days) The median survival time was 386 days for patients in Stages I + II, 338 days for those in Stage III, and 178 days for those in Stage IV. There was no significant difference between the survival curves of Stages I + II and Stage III, but the survival rate of the patients in Stages I + II was significantly better than that for those in Stage IV (p<0.01). Survivability of patients with pleural by treatment Survival rate (%) Surgical cases Non-surgical cases Survival time (days) The median survival time was 549 days for the surgically resected cases and 305 days for the non-resected cases. There was a statistically significant difference (p<0.05).
9 Survey of Mesothelioma Associated with Asbestos Exposure in Japan Occupational asbestos exposure Occupational asbestos exposure (-) 15.9 Occupational asbestos exposure (+) 84.1 Frequency of occupational asbestos exposure Pleural Peritoneal Cases Shipyard work Construction Insulation Plumbing Asbestos product manufacturing Electrical industry Mechanical device manufacturing Driver Vehicle manufacturing Dismantling Work in warehouse Car manufacturing/repair Sheet metal work Other asbestos-related work identified cases Number of unidentified cases Four cases of pericardial and two cases of of the tunica vaginalis were included. The occupational history was investigated in 201 of the 221 cases. Among these cases, 169 (84.1%) were considered to be associated with occupational asbestos exposure. Clinical characteristics of 221 cases treated in 27 Rosai Hospitals
10 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Duration of asbestos exposure, age at initial exposure, and latent period Duration of asbestos exposure, age at initial exposure, and latent period Primary site Item No. of cases Median Range Mean SD Pleura Duration of exposure (years) Age at initial exposure Latent period (years) Peritoneum Duration of exposure (years) Age at initial exposure Latent period (years) Duration of exposure (years) Age at initial exposure Latent period (years) One case of of the tunica vaginalis and one case of unknown origin were included. The latent period was 42.6 years for cases of pleural and 43.4 years for cases of peritoneal. Radiographical findings of asbestos-related changes Region Radiographical findings of asbestos-related changes Pleura Peritoneum Pericardium Tunica vaginalis Number of cases Evaluated cases Radiographical changes Pulmonary asbestosis Pleural plaque Hyaline degeneration Calcification Round atelectasis Diffuse pleural thickening Pleural effusion Pleural effusion was noted in many cases accounting for 76.8% of the cases, and pleural plaque was present in 50.2% of the cases.
11 Survey of Mesothelioma Associated with Asbestos Exposure in Japan Number of asbestos bodies in the lung Number of asbestos bodies in the lung (per gram of dry lung tissue) Pleural plaque Present Absent cases Cases examined Mean SD Maximum Minimum < 1,000 1,000-5,000 >5,000 All 45 cases were diagnosed with pleural. From the 45 cases with pleural in which asbestos bodies in the lung were counted, 1,000 or more intrapulmonary asbestos bodies per gram of dry lung tissue were detected in 25 of 30 cases with pleural plaque (83.3%), and 10 of 15 cases without plaque (66.7%). Compared to the interim report of the Survey of lung cancer and malignant cases associated with asbestos exposure published in May 2006, we found the important points given below. In the interim report, 89 of 117 cases (76.1%) provided information regarding asbestos exposure in the occupational history; however, this increased to 84.1% (169/201) in this report. The awareness of physicians to obtain a detailed occupational history may have increased.. The disease was identified during a regular health check-up in 12 of 132 cases (9.1%) in the interim report, and in 28 of 219 cases (12.8%) in this report. This shows an increase in the proportion of detection at regular health check-ups. Clinical characteristics of 221 cases treated in 27 Rosai Hospitals
12 The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Histological diagnosis was obtained in 78.8% of the cases in the interim report and 84.0% of the cases in this report. This indicates that the physicians are utilizing histological testing more often and recognizing the importance of histological diagnosis.. Thoracoscopy under local anesthesia was performed in 13.4% of the cases in the interim report, and increased to 19.0% of the cases in this report. This indicates that thoracoscopy under local anesthesia has been performed more widely as a diagnostic procedure.. The level of medical care for has been improving in Japan, but the proportion of diagnosis at Stages I and II remained low (29.6%) in this report, and the survival rate was poor. Development of procedures for early detection and further educational activities in general practice are necessary. Comparison between interim and current reports Interim report (Jan 2000-Feb 2006) Current report (Jan 2000-Jan 2008) Cases during Mar 2006-Jan 2008 Occupational asbestos exposure 89 of 117 cases 169 of 201 cases 80 of 84 cases Diagnosed during regular health check-up 12 of 132 cases 28 of 219 cases 16 of 87 cases Histologically diagnosed cases of pleural 104 of 132 cases 184 of 219 cases 80 of 87 cases Measurement of pleural hyaluronic acid concentration in pleural cases 43 of 112 cases 94 of 184 cases 51 of 72 cases Thoracoscopy under local anesthesia in pleural cases 15 of 112 cases 35 of 184 cases 20 of 72 cases All items were markedly improved during the period between the interim and current reports (March 2006-January 2008).
13 List of investigatorsfield of Asbestos-Related Diseases Takumi Kishimoto, MD Ikuji Usami, MD Kazuo Oonishi, MD Kiyonobu Kimura, MD Kenichi Genba, MD Ikuo Nakano, MD Nobukazu Fujimoto, MD Keiichi Mizuhashi, MD Chief, Clinical Research Center for Asbestos-Related Diseases,Okayama Rosai Hospital Vice Director General, Asahi Rosai Hospital Vice Director General, Kobe Rosai Hospital Director General, Hokkaido Chuo Rosai Hospital Director, Department of Respiratory Diseases, Okayama Rosai Hospital Vice Director General, Hokkaido Chuo Rosai Hospital Deputy Director, Department of Respiratory Diseases, Okayama Rosai Hospital Chief, Clinical Research Center for Asbestos-Related Diseases, Toyama Rosai Hospital The research is a part of the research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses of the Japan Labour Health and Welfare Organization. Field name: Asbestos-Related Diseases Theme name: The research and development and the dissemination related to diagnosis, treatment, and prophylaxis of induced by asbestos exposure.
3- B ~ E. Asbestos-Related Respiratory Diseases Takumi Kishimoto Deputy-director, Okayama Rosai Hospital, Japan Summary For the pulmonary diseases arising from asbestos there are benign lesions from asbestosis
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
PLEURAL MESOTHELIOMA PLEURAL MESOTHELIOMA By: Domenico Galetta Institute of Oncology Giovanni Paolo II I.R.C.C.S. Oncology Hospital of Bari, Italy Silvia Novello University of Torino, Italy San Luigi Hospital
& MALIGNANT PLEURAL MESOTHELIOMA TREATED IN CLINIC FOR PULMONARY DISEASES AND TUBERCULOSIS PODHRASTOVI IN TEN-YEAR PERIOD ( FROM 1998 TO 2007 ) Vesna Čukić*, Aida Ustamujić, Vladimir Lovre, Hasan Žutić,
australian mesothelioma registry 2nd Annual Report Mesothelioma in Australia 2012 The Australian Mesothelioma Registry is funded by Safe Work Australia and Comcare. Creative Commons ISBN 978-1-74361-136-4
SCREENING FOR MESOTHELIOMA Current recommendations for screening of patients who have been exposed to significant amounts of asbestos is that screening is not undertaken because there is no effective early
ASBESTOS RELATED LUNG DISEASE Version 2 Final Page 1 Document control Version history Version Date Comments 2 Final 19 January 2007 Signed off by MSCMT 2e (draft) 21 November 2006 Comments from MSCMT incorporated
REVIEW ARTICLE Asbestos-related Diseases in the Philippines: The Lung Center of the Philippines Asbestos Screening Program Dina V. Diaz 1,2 1 Department of Physiology, College of Medicine, University of
Asbestosis in Louisiana: A Descriptive Review and Demographic Analysis of Hospitalizations for Asbestosis, 1999-2009 Cassandra Davis, MPH; Jayaprabha Vijaykumar MD, MPH; Michelle Lackovic, MPH; James H.
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through
American Thoracic Society Documents Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos This official statement of the American Thoracic Society was adopted by the ATS Board of
Ann Ist Super Sanità 2009 Vol. 45, No. 2: 147-161 147 Health surveillance for subjects with past exposure to asbestos: from international experience and Italian regional practices to a proposed operational
Eur Respir J 2010; 35: 479 495 DOI: 10.1183/09031936.00063109 CopyrightßERS Journals Ltd 2010 ERS/ESTS TASK FORCE Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons
Asbestos Fibres in Indoor and Outdoor Air AND The Epidemiology of Asbestos-related Diseases in Quebec * SUMMARY AND RECOMMENDATIONS OF THE REPORTS ABSTRACT In 1997, in light of international developments
Industrial Health 2012, 50, 197 204 Original Article Future Trends of Mesothelioma Mortality in Japan Based on a Risk Function Tomoya MYOJIN 1, Kenichi AZUMA 2 *, Jiro OKUMURA 2 and Iwao UCHIYAMA 3 1 Department
Ministry of Defence Synopsis of Causation Mesothelioma Author: Dr David Jenkins, Medical Author, Medical Text, Edinburgh Validator: Professor Mark Britton, St Peter s Hospital, Chertsey, Surrey September
ORIGINAL RESEARCH ARTICLE Tanaffos (2006) 5(4), 59-63 2006 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Malignant Mesothelioma: A Study of Sixty-Six Cases Ali Cheraghvandi
How to Treat PULL-OUT SECTION www.australiandoctor.com.au Complete How to Treat quizzes online (www.australiandoctor.com.au/cpd) to earn CPD or PDP points. inside Asbestos-related lung conditions Other
Exhibit A Kane Legal Mesothelioma Handbook Volume No. 1 David Kane, R.Ph., J.D. Professor of Pharmacy Law, Rutgers University Table of Contents Section 1 History of Asbestos...2 Section 2 - What is Mesothelioma?...3
www.edoriumjournals.com Case in Images OPEN ACCESS Omental mesothelioma as a diagnostic and therapeutic challenge: A case report Cihan Akgul Ozmen, Yekta Tuzun, Hatice Ozturkmen Akay, Hasan Nazaroglu ABSTRACT
GUIDE FOR PEOPLE EXPOSED TO ASBESTOS AND THOSE SUFFERING FROM THE RELATED DISEASES The Organisation for Respiratory Health in Finland seeks to promote respiratory health and the quality of life among people